Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario.

Cancer treatment and research communications - 1 Jan 2021

Sayed Shomoita

Abstract excerpt

BACKGROUND: Malignancy is one of the prime global causes of mortality. Cancer Patients suffering from SARS-CoV-2 have demonstrated higher rates of severe complications exacerbating towards death. Possible genetic and epigenetic alterations may exist in cancer patients which have the potential to contribute towards their increased vulnerability towards COVID-19. METHOD: An exhaustive literature search using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme 2
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19

Share to COVID-19 Vaccines

Share to Drug Carriers

Share to Epigenesis, Genetic

Share to Interleukin-6

Share to Vaccination

Source

Open in PubMed Open full text

Identifiers

PMID: 34171559
DOI: 10.1016/j.ctarc.2021.100425
PMCID: PMC8213508

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario.PMID 34171559Read ↗

Covid-19 And Cancer: Insights Into Their Association And Influence On Genetic And Epigenetic LandscapeSemantic proximity Read ↗

SARS-CoV-2 infection as a potential risk factor for the development of cancerSemantic proximity Read ↗

Assessing COVID-19 Infection, and Severe Disease Risk in Cancer Patients and Survivors: The Role of Vaccination Status, Circulating Variants, and Comorbidities—A Population-Based Study in Northern ItalySemantic proximity Read ↗

New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?Semantic proximity Read ↗

Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer PatientsSemantic proximity Read ↗

Safeguarding COVID-19 and cancer management: drug design and therapeutic approachSemantic proximity Read ↗

MicroRNAs are enriched at COVID-19 genomic risk regions, and their blood levels correlate with the COVID-19 prognosis of cancer patients infected by SARS-CoV-2Semantic proximity Read ↗

The intersection of COVID-19 and cancer: signaling pathways and treatment implicationsSemantic proximity Read ↗

Characteristics and outcome of SARS-CoV-2 infection in cancer patients.Semantic proximity Read ↗

Incidence and Immunomic Features of Apyretic COVID-19 in Patients Affected by Solid Tumors: a Prospective Cohort Study.Semantic proximity Read ↗

Possible cancer-causing capacity of COVID-19: Is SARS-CoV-2 an oncogenic agent?Semantic proximity Read ↗

Association of Cancer with Risk and Mortality of COVID-19: Results from the UK BiobankSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.